ProShares Ultra CRCL (CRCA) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 154 252 sessions, September 17, 2025 to September 17, 2026
- Largest daily move
- +70.2% close of February 25, 2026
- 1-year change
- -86.9% closing prices, September 17, 2025 to September 17, 2026
Company Description
ProShares Ultra CRCL (CRCA) is an exchange-traded fund offered by ProShares, an ETF sponsor known for geared strategies, including leveraged and inverse ETF investing. The fund is part of a ProShares lineup that includes products tied to dividend growth, high income, interest-rate-hedged bonds, crypto exposure, and tactical ETF strategies.
As a ProShares ETF, ProShares Ultra CRCL is associated with fund-level mechanics and risks typical of the sponsor's geared products. ProShares materials describe its ETFs as generally non-diversified and note that certain funds may use derivatives such as swap agreements, futures contracts, and similar instruments. These instruments, along with leverage, imperfect benchmark correlation, and market price variance, can increase volatility and affect fund performance.
Recent ProShares fund communications also address ETF share actions such as reverse share splits. A reverse split changes the number of shares outstanding and the per-share trading price but does not, by itself, change the total value of a shareholder's investment. CRCA's public-company profile is therefore best understood as a fund reference record tied to ProShares' ETF platform rather than as an operating business with products, customers, or operating segments.
Stock Performance
ProShares Ultra CRCL (CRCA) closed at $19.18 on September 17, 2026. Over the past 12 months, the price has lost 86.9%.
CRCA Metrics & Rankings
Price returns through September 17, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
ProShares Ultra CRCL has 2 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. View all CRCA news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in ProShares Ultra CRCL (CRCA) currently stands at 1.5 million shares, up 11.7% from the previous reporting period, representing 25.5% of the shares outstanding. Since September 2025, short interest has increased by 6100.7%.
Days to Cover History
Days to cover for ProShares Ultra CRCL (CRCA) currently stands at 1.4 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has increased 35% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.0 to 1.6 days.